Stay updated on Gebasaxturev Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.

Latest updates to the Gebasaxturev Combo in Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.3 was added to the history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedThe history now adds Revision: v3.3.2 and removes Revision: v3.2.0; this is a minor metadata update to the record history that does not affect study data or status.SummaryDifference0.1%

- Check50 days agoChange DetectedThe site-wide government funding/operating status notice has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedThe new screenshot shows a visual refresh of the Record History page, with the same version entries and no changes to the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference9%

- Check100 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.2%

Stay in the know with updates to Gebasaxturev Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.